In response, a global health emergency was launched that led to further disruptions in the ordinary way of life of people. Since its emergence, Coronavirus Disease 2019 (COVID-19) has infected over half a billion people, killed over 6 million others, and ravaged the global economy on a scale that is unprecedented in recent history. Ĭenters for Disease Control and Prevention Antibiotic Use Questions and Answers. The KAP Survey Model (Knowledge, Attitudes, & Practices). A systematic review of the public’s knowledge and beliefs about antibiotic resistance. McCullough A.R., Parekh S., Rathbone J., Del Mar C.B., Hoffmann T.C. General population’s knowledge and attitudes about antibiotics: A systematic review and meta-analysis. Gualano M.R., Gili R., Scaioli G., Bert F., Siliquini R. Surveys of knowledge and awareness of antibiotic use and antimicrobial resistance in general population: A systematic review. Kosiyaporn H., Chanvatik S., Issaramalai T., Kaewkhankhaeng W., Kulthanmanusorn A., Saengruang N., Witthayapipopsakul W., Viriyathorn S., Kirivan S., Kunpeuk W., et al. The validity of the KAP-questionnaire on antibiotics in Arabic and French was demonstrated in Lebanon.Īrabic French Lebanon antibiotics knowledge–attitude–practice questionnaire validation. The questionnaire showed an acceptable internal reliability (Cronbach's alpha = 0.62) and was highly accepted in Lebanon (response rate = 96% and item response rates ≥ 94%). CFA evidenced adequate fit of the chosen model, thus establishing the construct validity of the questionnaire (root mean squared error approximation = 0.053, standardized root mean square residual = 0.045, comparative fit index = 0.92 and Tucker-Lewis index = 0.90). Test-retest reliability analysis (N = 100) yielded ICC ≥ 0.59 for all knowledge and attitude items, showing the capacity of the questionnaire to generate reproducible results. Pilot testing (N = 40) and face validity showed the understandability of the questionnaire by the population. ICV-I (>0.78), k* (equal to ICV-I for all items) and S-CVI/Ave (≥0.95) confirmed the questionnaire content validity. The construct validity of the questionnaire was evaluated using confirmatory factorial analysis (CFA, N = 1460) and its reliability was assessed using intraclass correlation coefficients (ICC, N = 100) and Cronbach's alpha statistic. The item content validity index (I-CVI), scale content validity index (S-CVI/Ave) and modified Kappa (k*) were calculated. We translated the previously developed KAP-questionnaire into Arabic and French, tailored it and then validated it in adult population in Lebanon. Here, we aimed to validate the questionnaire in a developing country with different socioeconomic characteristics from that of Spain. Cross-cultural adaptation and validation of research tools increase their universal usefulness. Recently, we validated the first KAP questionnaire on antibiotics in Spain. Validated knowledge-attitude-practice (KAP) questionnaires are essential to design and evaluate intervention programs on antibiotic use. 11 Department of Respiratory Medicine, University Hospital of Santiago de Compostela (CHUS), 15706 Santiago de Compostela, Spain.10 Department of Medicine, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain.9 Health Research Institute of Santiago de Compostela (IDIS), 15706 Santiago de Compostela, Spain.8 Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBER-ESP), 28029 Madrid, Spain.
7 INSPECT-LB, Institut National de Santé Publique, Epidémiologie Clinique et Toxicologie, Beirut 1100, Lebanon.6 Faculty of Health Sciences, American University of Science and Technology, Beirut 1100, Lebanon.5 PROMENTA Research Center, Department of Psychology, University of Oslo, 0315 Oslo, Norway.4 Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBER-ES), 28029 Madrid, Spain.3 Genetics, Vaccines and Pediatric Infectious Diseases Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago de Compostela, 15706 Santiago de Compostela, Spain.2 WHO Collaborating Centre for Vaccine Safety, 15706 Santiago de Compostela, Spain.1 Department of Preventive Medicine, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain.
0 kommentar(er)
